Triangle Pharmaceuticals, which was taken over by Gilead Sciences Pharmasset, also taken over by Gilead Idenix Pharmaceuticals, taken over by Merck for $3.85 billion[52] RFS Pharma, which merged with Cocrystal Pharma.